Anyone affected by Alport syndrome, regardless of sex-linked or non sex-linked inheritance patterns, has a genetic mutation that defines the condition. Every patient is at risk of developing severe disease.5,7,8
Learn more about the genetics of Alport syndrome
Look beyond the expected population
Common misdiagnoses for Alport syndrome include7,9,10:
10% of patients have a genetic cause of CKD11
Alport syndrome occurs when genetic variants in the COL4A3/4/5 genes are present. One exome sequencing analysis of 3315 patients reported that 10% of CKD patients had a genetic cause of disease. Of these patients, 30% had COL4A mutations.
30% of those with a genetic cause had a mutation in
Of those patients with COL4A3/4/5 mutations, 62% were misdiagnosed or not diagnosed with Alport syndrome or TBMN
CKD=chronic kidney disease; COL4A=collagen type 4A; PKD=polycystic kidney disease; TBMN=thin basement membrane nephropathy; HTN=hypertensive nephropathy; GN=glomerulosclerosis; NOS=not otherwise specified; FSGS=focal segmental glomerulosclerosis.
Highlight Alport syndrome by recognizing the following signs:
Genetic testing for Alport syndrome and several other rare forms of chronic kidney disease is more accessible than ever before. Find out the eligibility requirements for no-charge genetic testing through KIDNEYCODE.
You are now leaving Alportsyndrome.com
You are leaving alportsyndrome.com and connecting to a site that is not under the control of Reata Pharmaceuticals, Inc. (“Reata”).
Reata is not responsible for the contents of any such site or any further links from such site. Reata is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by Reata.